Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human engineered monoclonal antibody specific for Transforming Growth Factor ß1

EU orphan designation number: EU/3/01/080
Active ingredient: Human engineered monoclonal antibody specific for Transforming Growth Factor ß1
Indication: Treatment of systemic sclerosis
Sponsor: Genzyme Europe B.V.
Gooimeer 10, 1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/02/2002 Orphan designation EMEA/OD/051/01 (2002)468 of 04/02/2002
10/11/2005 Removal of orphan designation from Community Register